Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis Post author: Post published:May 29, 2024 Post category:uncategorized The antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced keratitis You Might Also Like Want to eat slower? Pick meals that need chopsticks, not hands May 5, 2025 Machine learning model can predict 28-day mortality in sepsis patients March 27, 2026 Exploring the relationship between non-coding RNAs and oxidative stress in cancer progression March 5, 2025
Exploring the relationship between non-coding RNAs and oxidative stress in cancer progression March 5, 2025